AR047712A1 - Metodo de tratamiento de una lesion de tejido esqueletico blando natural administrando una composicion de celulas madre mesenquimatosas - Google Patents

Metodo de tratamiento de una lesion de tejido esqueletico blando natural administrando una composicion de celulas madre mesenquimatosas

Info

Publication number
AR047712A1
AR047712A1 ARP030103236A ARP030103236A AR047712A1 AR 047712 A1 AR047712 A1 AR 047712A1 AR P030103236 A ARP030103236 A AR P030103236A AR P030103236 A ARP030103236 A AR P030103236A AR 047712 A1 AR047712 A1 AR 047712A1
Authority
AR
Argentina
Prior art keywords
composition
skelettic
mesenquimatose
managing
treatment method
Prior art date
Application number
ARP030103236A
Other languages
English (en)
Original Assignee
Royal Veterinary College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0220841A external-priority patent/GB0220841D0/en
Priority claimed from GB0226275A external-priority patent/GB0226275D0/en
Application filed by Royal Veterinary College filed Critical Royal Veterinary College
Publication of AR047712A1 publication Critical patent/AR047712A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/33—Fibroblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue

Abstract

Un método para el tratamiento de una lesion de tejido esquelético blando natural en un paciente, donde dicho método comprende administrar al paciente una composicion de células madre mesenquimatosas en una suspension líquida enriquecida, comparada con la fuente natural de dichas células, o tenocitos derivados de las mismas. El método es particularmente adecuado para la regeneracion de tendones en mamíferos de competicion, tales como el tendon flexor digital superficial del caballo. El uso de dicha composicion.
ARP030103236A 2002-09-07 2003-09-05 Metodo de tratamiento de una lesion de tejido esqueletico blando natural administrando una composicion de celulas madre mesenquimatosas AR047712A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0220841A GB0220841D0 (en) 2002-09-07 2002-09-07 Therapy
GB0226275A GB0226275D0 (en) 2002-11-12 2002-11-12 Method of treatment

Publications (1)

Publication Number Publication Date
AR047712A1 true AR047712A1 (es) 2006-02-15

Family

ID=31980022

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030103236A AR047712A1 (es) 2002-09-07 2003-09-05 Metodo de tratamiento de una lesion de tejido esqueletico blando natural administrando una composicion de celulas madre mesenquimatosas

Country Status (10)

Country Link
US (5) US8178084B2 (es)
EP (3) EP1545567B1 (es)
AR (1) AR047712A1 (es)
AT (2) ATE389412T1 (es)
AU (1) AU2003263340B2 (es)
CA (1) CA2538187C (es)
DE (2) DE60319848T2 (es)
ES (1) ES2304541T3 (es)
NZ (1) NZ539308A (es)
WO (1) WO2004022078A1 (es)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7608258B2 (en) 2002-04-13 2009-10-27 Allan Mishra Method for treatment of tendinosis using platelet rich plasma
US6811777B2 (en) 2002-04-13 2004-11-02 Allan Mishra Compositions and minimally invasive methods for treating incomplete connective tissue repair
US7429378B2 (en) 2003-05-13 2008-09-30 Depuy Spine, Inc. Transdiscal administration of high affinity anti-MMP inhibitors
AU2004291065B2 (en) * 2003-05-13 2007-11-01 Depuy Spine, Inc. Autologous treatment of degenerated disc with cells
US8273347B2 (en) 2003-05-13 2012-09-25 Depuy Spine, Inc. Autologous treatment of degenerated disc with cells
US7344716B2 (en) 2003-05-13 2008-03-18 Depuy Spine, Inc. Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
US7553827B2 (en) 2003-08-13 2009-06-30 Depuy Spine, Inc. Transdiscal administration of cycline compounds
US8361467B2 (en) 2003-07-30 2013-01-29 Depuy Spine, Inc. Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
WO2005035742A2 (en) 2003-10-08 2005-04-21 Vet-Stem Inc. Methods of preparing and using stem cell compositions and kits comprising the same
US8895540B2 (en) 2003-11-26 2014-11-25 DePuy Synthes Products, LLC Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
WO2005065242A2 (en) 2003-12-29 2005-07-21 Am Biosolutions Method of treating cancer using platelet releasate
US7462268B2 (en) 2004-08-20 2008-12-09 Allan Mishra Particle/cell separation device and compositions
KR100593397B1 (ko) * 2004-10-27 2006-06-28 한국원자력연구소 중배엽 줄기세포 및/또는 ｐ 물질을 함유하는 상처 치유또는 상처 치유 촉진제, 또는 세포 치료제
ES2671873T3 (es) 2007-04-24 2018-06-11 Orthocell Limited Bioestructuras que contienen tenocitos y tratamiento utilizando las mismas
US8785191B2 (en) * 2007-08-27 2014-07-22 University Of Connecticut Concentration of stem cells obtained during orthopaedic surgeries
WO2009074807A2 (en) 2007-12-12 2009-06-18 Imperial Innovations Limited Methods
US8986696B2 (en) 2007-12-21 2015-03-24 Depuy Mitek, Inc. Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints
IT1394262B1 (it) * 2008-07-17 2012-06-01 Università Degli Studi Di Milano Metodo per la produzione in vitro di tenociti a partire da cellule staminali mesenchimali, nonché rispettivi metodi per la caratterizzazione di detti tenociti e di dette cellule staminali mesenchimali
US20100112081A1 (en) 2008-10-07 2010-05-06 Bioparadox, Llc Use of platelet rich plasma composition in the treatment of cardiac conduction abnormalities
GB0820492D0 (en) * 2008-11-07 2008-12-17 Sportcell Cell compositions and uses thereof
WO2010140162A2 (en) * 2009-05-17 2010-12-09 Dravida Subhadra A process for preparing stem cell based formulations
DE102010046218A1 (de) 2010-09-21 2012-03-22 Livlmplant Gmbh Zell-basiertes Injektionssystem zur Behandlung von Verletzungen
EP3141599B1 (en) * 2011-03-18 2022-12-21 MicroVascular Tissues, Inc. Allogeneic microvascular tissue for soft tissue treatments
CN104471059B (zh) 2012-07-12 2018-04-17 珠海横琴爱姆斯坦生物科技有限公司 人胚胎干细胞衍生的间充质样干细胞、方法及其应用
US11819522B2 (en) 2012-09-19 2023-11-21 Microvascular Tissues, Inc. Compositions and methods for treating and preventing tissue injury and disease
WO2014047067A1 (en) 2012-09-19 2014-03-27 Tornier, Inc. Compositions and methods for treating and preventing tissue injury and disease
US9872937B2 (en) 2012-09-19 2018-01-23 Microvascular Tissues, Inc. Compositions and methods for treating and preventing tissue injury and disease
US10596202B2 (en) 2012-09-19 2020-03-24 Microvascular Tissues, Inc. Compositions and methods for treating and preventing tissue injury and disease
WO2014167142A1 (es) 2013-04-09 2014-10-16 Equicord, S.L. Procedimiento para el tratamiento de células madre mesenquimales equinas y sistema para llevar a cabo el procedimiento
US20140356893A1 (en) 2013-06-04 2014-12-04 Allan Mishra Compositions and methods for using platelet-rich plasma for drug discovery, cell nuclear reprogramming, proliferation or differentiation
EP3083944B1 (en) * 2013-12-19 2020-12-09 Université de Liège Mammalian muscle-derived stem cells
WO2016015007A1 (en) 2014-07-25 2016-01-28 Recellerate, Inc. Methods of treating exercise-induced pulmonary hemorrhage
WO2016073989A2 (en) * 2014-11-07 2016-05-12 The Trustees Of Columbia University In The City Of New York Osteochondroreticular stem cells for bone and cartilage regeneration
RU2644650C2 (ru) 2014-12-01 2018-02-13 Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" Материал стволовых клеток и способ его получения
WO2016172004A1 (en) * 2015-04-18 2016-10-27 The Johns Hopkins University Bone healing, angiogenesis-promoting and vasculogenesis-producing system
WO2017059089A1 (en) * 2015-09-29 2017-04-06 Anicell Biotech, Llc Methods and articles of manufacture for the treatment of animals
US9861410B2 (en) 2016-05-06 2018-01-09 Medos International Sarl Methods, devices, and systems for blood flow
RU2708329C2 (ru) 2016-05-31 2019-12-05 Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" Материал стволовых клеток, композиции и способы применения
CN106308817B (zh) * 2016-08-12 2023-07-28 玉溪九洲生物技术有限责任公司 一种马血浆采集系统
FR3058065B1 (fr) * 2016-10-27 2019-02-01 Scarcell Therapeutics Composition pour le traitement d’une affection de l’appareil locomoteur
EP3388511A1 (en) * 2017-04-12 2018-10-17 Revatis SA New uses of mammalian muscle derived stel cells
WO2021041858A1 (en) * 2019-08-29 2021-03-04 Icahn School Of Medicine At Mount Sinai Differentiated tendon cells derived from pluripotent progenitor cells and methods of use thereof
RU2722162C1 (ru) * 2019-10-14 2020-05-27 Федеральное государственное бюджетное учреждение науки Сибирский федеральный научный центр агробиотехнологий Российской академии наук (СФНЦА РАН) Способ лечения травм сухожильно-связочного аппарата у лошадей

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811094A (en) * 1990-11-16 1998-09-22 Osiris Therapeutics, Inc. Connective tissue regeneration using human mesenchymal stem cell preparations
US5837539A (en) 1990-11-16 1998-11-17 Osiris Therapeutics, Inc. Monoclonal antibodies for human mesenchymal stem cells
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US6010696A (en) 1990-11-16 2000-01-04 Osiris Therapeutics, Inc. Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells
US5733542A (en) 1990-11-16 1998-03-31 Haynesworth; Stephen E. Enhancing bone marrow engraftment using MSCS
US5226914A (en) 1990-11-16 1993-07-13 Caplan Arnold I Method for treating connective tissue disorders
WO1996003160A1 (en) * 1994-07-26 1996-02-08 Children's Medical Center Corporation Fibrin-cell suspension for construction of new tissue
US5906934A (en) 1995-03-14 1999-05-25 Morphogen Pharmaceuticals, Inc. Mesenchymal stem cells for cartilage repair
DE69636289T2 (de) 1995-12-18 2007-05-10 Angiodevice International Gmbh Vernetzten polymerisatmassen und verfahren für ihre verwendung
US6200606B1 (en) 1996-01-16 2001-03-13 Depuy Orthopaedics, Inc. Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration
US6280473B1 (en) * 1996-08-19 2001-08-28 Macropore, Inc. Resorbable, macro-porous, non-collapsing and flexible membrane barrier for skeletal repair and regeneration
WO1998051317A1 (en) 1997-05-13 1998-11-19 Osiris Therapeutics, Inc. Osteoarthritis cartilage regeneration using human mesenchymal stem cells
DK1007631T4 (da) * 1997-07-14 2009-04-27 Osiris Therapeutics Inc Hjertemuskelregeneration ved anvendelse af mesenkymale stamceller
US20020123143A1 (en) * 1997-08-22 2002-09-05 Jean Toma Multipotent stem cells from peripheral tissues and uses thereof
CA2323073C (en) * 1998-03-13 2010-06-22 Osiris Therapeutics, Inc. Uses for human non-autologous mesenchymal stem cells
US6835377B2 (en) * 1998-05-13 2004-12-28 Osiris Therapeutics, Inc. Osteoarthritis cartilage regeneration
DE69937888T2 (de) * 1998-07-31 2009-01-02 Genzyme Corp., Cambridge Verfahren zur Herstellung mesenchymaler Stammzellen
AU2998300A (en) 1999-02-17 2000-09-04 United States Surgical Corporation Genetically altered mesenchymal stem cells and methods of use thereof
FR2799371A1 (fr) * 1999-10-12 2001-04-13 Univ Paris Curie Compositions de tenocytes preparation et utilisations
EP1099754A1 (en) 1999-11-10 2001-05-16 Universiteit Leiden Mesenchymal stem cells and/or progenitor cells, their isolation and use
EP2283880A3 (en) * 2000-03-20 2014-07-09 Biosphere Medical, Inc. Injectable microspheres for tissue construction
EP1276486B2 (en) 2000-04-25 2014-03-05 Osiris Therapeutics, Inc. Joint repair using mesenchymal stem cells
US20020045260A1 (en) * 2000-10-17 2002-04-18 Shih-Chieh Hung Method of isolating mesenchymal stem cells
AU2002224444A1 (en) * 2000-10-24 2002-05-06 Children's Hospital Of Philadelphia Therapeutic uses for mesenchymal stromal cells
JP4959916B2 (ja) 2001-08-14 2012-06-27 メディポスト・カンパニー・リミテッド 関節軟骨損傷治療用組成物
US6811777B2 (en) * 2002-04-13 2004-11-02 Allan Mishra Compositions and minimally invasive methods for treating incomplete connective tissue repair

Also Published As

Publication number Publication date
AU2003263340B2 (en) 2008-12-18
US20060130852A1 (en) 2006-06-22
ATE494898T1 (de) 2011-01-15
DE60319848D1 (de) 2008-04-30
DE60319848T2 (de) 2009-04-30
US8178084B2 (en) 2012-05-15
EP1872789B1 (en) 2011-01-12
AU2003263340A1 (en) 2004-03-29
DE60335752D1 (es) 2011-02-24
CA2538187A1 (en) 2004-03-18
NZ539308A (en) 2008-03-28
CA2538187C (en) 2019-01-08
WO2004022078A1 (en) 2004-03-18
US20130039896A1 (en) 2013-02-14
EP2316462A1 (en) 2011-05-04
EP1545567A1 (en) 2005-06-29
ES2304541T3 (es) 2008-10-16
US20150017145A1 (en) 2015-01-15
US20120230960A1 (en) 2012-09-13
EP1545567B1 (en) 2008-03-19
ATE389412T1 (de) 2008-04-15
US20170258848A1 (en) 2017-09-14
EP1872789A1 (en) 2008-01-02

Similar Documents

Publication Publication Date Title
AR047712A1 (es) Metodo de tratamiento de una lesion de tejido esqueletico blando natural administrando una composicion de celulas madre mesenquimatosas
Nourissat et al. Mesenchymal stem cell therapy regenerates the native bone-tendon junction after surgical repair in a degenerative rat model
Grier et al. The influence of pore size and stiffness on tenocyte bioactivity and transcriptomic stability in collagen-GAG scaffolds
Singh Mohal et al. Sources of adult mesenchymal stem cells and their applicability for musculoskeletal applications
AR109995A2 (es) Método para inhibir la resorción ósea
Andia et al. Current concepts and translational uses of platelet rich plasma biotechnology
Wang et al. Application of tendon stem/progenitor cells and platelet-rich plasma to treat tendon injuries
AR077573A2 (es) Uso de un inhibidor de tnf y composicion farmaceutica que lo comprende
CR9181A (es) Antiangiogenesis terapia de autoinmunidad de enfermedad en pacientes a quienes a fallado la terapia previa
BR0308928A (pt) Uso de toxina botulìnica para o tratamento de doenças cardiovasculares, bem como composição para uso em um procedimento cardiovascular
CR8126A (es) Metodo y dispositivo para tratar osteoartritis , enfermedad, defectos y lesiones del cartilago en la rodilla humana
HRP20120887T1 (en) Adherent cells from adipose or placenta tissues and use thereof in therapy
ES2572211T3 (es) Regeneración de músculo esquelético utilizando células madre mesenquimales
AR028678A1 (es) Nuevos compuestos de la familia de las n-acilamino-amidas, composiciones que los comprenden, y utilizaciones
RU2017139096A (ru) Композиция, содержащая биосовместимый матрикс, способ получения композиции
EP2787923B1 (en) Decellularized composite tissue bioscaffolds for musculoskeletal tissue interface reconstruction and methods of production
Narayanan et al. Musculoskeletal tissue regeneration: The role of the stem cells
JP2017530151A5 (es)
Huang et al. Current tissue engineering approaches for cartilage regeneration
EA201490995A1 (ru) Использование фо-ти для усиления мобилизации и пролиферации стволовых клеток
du Toit et al. Soft and hard-tissue augmentation with platelet-rich plasma: Tissue culture dynamics, regeneration and molecular biology perspective
HK1205531A1 (en) Mesenchymal stem cells and uses therefor
ATE414522T1 (de) Verfahren zur behandlung von akuter und durch übermässige beanspruchung verursachter zerrung und verstauchung mit hyaluronsäure
RU2013147265A (ru) РЕГЕНЕРАЦИЯ КОСТЕЙ И ХРЯЩЕЙ С ПОМОЩЬЮ АУТОЛОГИЧНЫХ ПЛЮРИПОТЕНТНЫХ ОЧЕНЬ МАЛЕНЬКИХ ЭМБРИОНОПОДОБНЫХ (hVSEL) СТВОЛОВЫХ КЛЕТОК ВЗРОСЛЫХ ЛЮДЕЙ
Zhang et al. Tendon-derived stem cells as a new cell source for tendon tissue engineering

Legal Events

Date Code Title Description
FA Abandonment or withdrawal